{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:15:40Z","timestamp":1789658140230,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1124\/mol.108.046201","type":"journal-article","created":{"date-parts":[[2008,6,25]],"date-time":"2008-06-25T02:48:40Z","timestamp":1214362120000},"page":"654-661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"title":["Inhibition of I\u03baB Kinase-Nuclear Factor-\u03baB Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin"],"prefix":"10.1016","volume":"74","author":[{"given":"Andrea L.","family":"Kasinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shala L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Yong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadlo R.","family":"Khuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Liotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.108.046201_REF1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00001813-200503000-00005","article-title":"EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism","volume":"16","author":"Adams","year":"2005","journal-title":"Anticancer Drugs"},{"key":"10.1124\/mol.108.046201_REF2","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1016\/j.bmc.2004.05.006","article-title":"Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents","volume":"12","author":"Adams","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/mol.108.046201_REF3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/mol.105.017400","article-title":"Curcumin (diferuloylmethane) downregulates expression of cell proliferation, antiapoptotic and metastatic gene products through suppression of I\u03baB\u03b1 kinase and AKT activation","volume":"69","author":"Aggarwal","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.108.046201_REF4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol Pharm"},{"key":"10.1124\/mol.108.046201_REF5","first-page":"3301","article-title":"Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation","volume":"13","author":"Beg","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.108.046201_REF6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2002-05-1320","article-title":"Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis","volume":"101","author":"Bharti","year":"2003","journal-title":"Blood"},{"key":"10.1124\/mol.108.046201_REF7","first-page":"2895","article-title":"Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions","volume":"21","author":"Cheng","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1124\/mol.108.046201_REF8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/00498259609046741","article-title":"Cytotoxicity and cytoprotective activities of natural compounds. The case of curcumin","volume":"26","author":"Commandeur","year":"1996","journal-title":"Xenobiotica"},{"key":"10.1124\/mol.108.046201_REF9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1158\/1535-7163.803.3.7","article-title":"Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand\/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation","volume":"3","author":"Deeb","year":"2004","journal-title":"Mol Cancer Ther"},{"issue":"18 Suppl","key":"10.1124\/mol.108.046201_REF10","doi-asserted-by":"crossref","first-page":"14151","DOI":"10.1200\/jco.2006.24.18_suppl.14151","article-title":"Phase II clinical trial of curcumin in patients with advanced pancreatic cancer","volume":"24","author":"Dhillon","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1124\/mol.108.046201_REF11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/mc.20217","article-title":"NF-kappaB and cancer: mechanisms and targets","volume":"45","author":"Karin","year":"2006","journal-title":"Mol Carcinog"},{"key":"10.1124\/mol.108.046201_REF12","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2174\/0929867013372229","article-title":"A review of cancer chemopreventive agents","volume":"8","author":"Levi","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1124\/mol.108.046201_REF13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-0-387-46401-5_10","article-title":"Molecular targets of curcumin","volume":"595","author":"Lin","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/mol.108.046201_REF14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1107\/S0108270104015434","article-title":"Curcumin and derivatives","volume":"60","author":"Mague","year":"2004","journal-title":"Acta Crystallogr C"},{"key":"10.1124\/mol.108.046201_REF15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/ar0201198","article-title":"Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials","volume":"36","author":"Meijer","year":"2003","journal-title":"Acc Chem Res"},{"key":"10.1124\/mol.108.046201_REF16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.278.5339.860","article-title":"IKK-1 and IKK-2 cytokine-activated IkappaB kinases essential for NF-kappaB activation","volume":"278","author":"Mercurio","year":"1997","journal-title":"Science"},{"key":"10.1124\/mol.108.046201_REF17","first-page":"999","article-title":"Altered expression of the p50 subunit of the NF-kappa B transcription factor complex in non-small cell lung carcinoma","volume":"11","author":"Mukhopadhyay","year":"1995","journal-title":"Oncogene"},{"key":"10.1124\/mol.108.046201_REF18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrc1588","article-title":"Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs","volume":"5","author":"Nakanishi","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/mol.108.046201_REF19","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1271\/bbb.59.1609","article-title":"Antioxidative activity of tetrahyrocurcuminids","volume":"59","author":"Osawa","year":"1995","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1124\/mol.108.046201_REF20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1021\/np060263s","article-title":"NMR study of the solution structure of curcumin","volume":"70","author":"Payton","year":"2007","journal-title":"J Nat Prod"},{"key":"10.1124\/mol.108.046201_REF21","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1038\/sj.onc.1203221","article-title":"Aberrant rel\/nfkb genes and activity in human cancer","volume":"18","author":"Rayet","year":"1999","journal-title":"Oncogene"},{"key":"10.1124\/mol.108.046201_REF22","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nri887","article-title":"Nf-kappa B, chemokine gene transcription and tumour growth","volume":"2","author":"Richmond","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/mol.108.046201_REF23","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1126\/science.7544915","article-title":"TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40","volume":"269","author":"Rothe","year":"1995","journal-title":"Science"},{"key":"10.1124\/mol.108.046201_REF24","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/jnci\/82.13.1113","article-title":"Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines","volume":"82","author":"Rubinstein","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/mol.108.046201_REF25","first-page":"651","article-title":"Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation","volume":"24","author":"Satoskar","year":"1986","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1124\/mol.108.046201_REF26","doi-asserted-by":"crossref","first-page":"28609","DOI":"10.1074\/jbc.M703796200","article-title":"EF24 induces G2\/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression","volume":"282","author":"Selvendiran","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.108.046201_REF27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2006-957450","article-title":"Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers","volume":"64","author":"Shoba","year":"1998","journal-title":"Planta Med"},{"key":"10.1124\/mol.108.046201_REF28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/187152006776930918","article-title":"Biological effects of curcumin and its role in cancer chemoprevention and therapy","volume":"6","author":"Singh","year":"2006","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1124\/mol.108.046201_REF29","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/mol.108.046201_REF30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","article-title":"Negative regulation of PKB\/Akt-dependent cell survival by the tumor suppressor PTEN","volume":"95","author":"Stambolic","year":"1998","journal-title":"Cell"},{"key":"10.1124\/mol.108.046201_REF31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1128\/MCB.24.3.1007-1021.2004","article-title":"Suppression of PTEN expression by NF-kappa B prevents apoptosis","volume":"24","author":"Vasudevan","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.108.046201_REF32","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1126\/science.274.5288.784","article-title":"TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB","volume":"274","author":"Wang","year":"1996","journal-title":"Science"},{"key":"10.1124\/mol.108.046201_REF33","doi-asserted-by":"crossref","first-page":"8511","DOI":"10.1073\/pnas.96.15.8511","article-title":"Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins","volume":"96","author":"Zhang","year":"1999","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24145233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24145233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.108.046201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T10:22:13Z","timestamp":1740046933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24145233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0026895X24145233"],"URL":"https:\/\/doi.org\/10.1124\/mol.108.046201","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of I\u03baB Kinase-Nuclear Factor-\u03baB Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.108.046201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}